-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Qualigen Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2017 to Q1 2024.
- Qualigen Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$784K, a 70.3% increase year-over-year.
- Qualigen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$10.3M, a 22.2% increase from 2022.
- Qualigen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$13.2M, a 10.1% increase from 2021.
- Qualigen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$14.7M.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)